{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sepsis/management/management/","result":{"pageContext":{"chapter":{"id":"e40708e7-39fd-5446-9536-8cf4c01bc2a9","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field b0b4100e-d36e-4a68-916c-aa0600a5693f --><h2>Management</h2><!-- end field b0b4100e-d36e-4a68-916c-aa0600a5693f -->","summary":"Covers the management of suspected sepsis in primary care, and the follow-up of sepsis survivors following hospital discharge.","htmlStringContent":"<!-- begin item 096655e3-964e-46b7-956f-aa0600a5693f --><!-- begin field ff400182-0c97-497d-ad8c-acbc0156e8c9 --><p>From age 1 month onwards.</p><!-- end field ff400182-0c97-497d-ad8c-acbc0156e8c9 --><!-- end item 096655e3-964e-46b7-956f-aa0600a5693f -->","topic":{"id":"6934ac75-4c45-5f2f-8c9a-2d8851f1adf5","topicId":"eab5610a-80e3-49d5-ac25-aa0600a5625f","topicName":"Sepsis","slug":"sepsis","lastRevised":"Last revised in April 2020","chapters":[{"id":"21403d5c-7f6a-58f8-a754-f80facfcc7b7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"01bfd22f-a788-595c-9d77-4f15e7d21471","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"8280962c-6cb2-53a1-8eed-ec18c19db62a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"02ea2408-9b6e-5954-a3bc-8305ad7c2b3d","slug":"changes","fullItemName":"Changes"},{"id":"c2a838a7-45f2-5a2b-8e94-13f83b057517","slug":"update","fullItemName":"Update"}]},{"id":"a1a6b520-0d3e-5568-8fcf-e882ce604048","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a9d2a1af-b338-5209-93b4-bddc7b6b5cbd","slug":"goals","fullItemName":"Goals"},{"id":"b2606ff0-0e97-55b2-83e3-4b0c5d0a2be2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3c4a84a7-c8f8-551b-bf15-639adaa8882d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"af6a0131-ac12-5bf9-9ae2-5a74b2adbde7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"379dd412-6848-5408-bbec-b555f59bfc67","slug":"qipp","fullItemName":"QIPP"},{"id":"cae1293c-e888-54e5-a1dd-6f9b76935048","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e59cb5ea-715e-5c86-a9eb-1321bb0a362f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6ca10715-009f-5d48-ae98-5f1104993328","slug":"definition","fullItemName":"Definition"},{"id":"25449018-76ee-5a28-ba72-210726d864df","slug":"causes","fullItemName":"Causes"},{"id":"2e720b24-f767-5b2a-98e1-3cac09695ebc","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fe40a4b7-90d6-5125-8498-68e555cda754","slug":"prevalence","fullItemName":"Prevalence"},{"id":"88dcfc30-9b7f-5f3e-8dc9-6f5bb11802f3","slug":"complications","fullItemName":"Complications"},{"id":"5dbce53d-7615-52d2-9cb1-c0464ff30dbb","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"96778028-ae23-5d58-96db-6778ae09539c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"31213219-a7d3-56db-9cfe-497952324a5b","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"fcf9d6d1-de70-585a-872d-39f4a36dd779","slug":"assessment","fullItemName":"Assessment"},{"id":"01c98f9e-2c4f-5551-96f8-b3842afc11ed","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75ccb28e-2583-5018-b95b-9534f5c406cf","fullItemName":"Management","slug":"management","subChapters":[{"id":"e40708e7-39fd-5446-9536-8cf4c01bc2a9","slug":"management","fullItemName":"Scenario: Management"},{"id":"34acc039-3bd9-55d2-86cd-3425bafcb304","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"c0cc5534-3a65-5215-b06f-82d0952f8728","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"78019898-1022-5b3f-bced-95df62a87a55","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7d6600d7-11ae-522d-8267-927494750ab2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"47e69ad2-af94-5cf1-9cb9-9a765667697b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b93e807a-0902-5c86-be52-22d6b24c8c21","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"74decb37-dae1-574b-b0d6-e9fd1505b280","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"df2e239f-4f1b-5ef3-8d0a-47b08ab0e887","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"dd29e46f-df2c-5e1c-b46a-1b6d3a95edbe","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"75ccb28e-2583-5018-b95b-9534f5c406cf","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1090627d-88ee-5b02-a970-ea33c691cb6f","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 19cf66a9-c404-45b9-8835-aa0600a5693f --><h3>How should I manage a person with suspected sepsis?</h3><!-- end field 19cf66a9-c404-45b9-8835-aa0600a5693f -->","summary":null,"htmlStringContent":"<!-- begin item d5b074e3-9fc3-4255-a492-aa0600a5693f --><!-- begin field bd0d3bff-fbbd-407b-b88e-aa0600a5693f --><p><strong>If a person has <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/diagnosis/\">suspected sepsis</a>, consider arranging emergency transfer to hospital or ongoing management in primary care, depending on the risk of clinical deterioration from sepsis following <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/assessment/\">assessment</a> and on clinical judgement.</strong></p><ul><li>If the person has <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/diagnosis/\">suspected neutropenic sepsis</a>, arrange immediate hospital assessment in secondary or tertiary care. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/neutropenic-sepsis/\">Neutropenic sepsis</a> for more information.</li><li>If neutropenic sepsis is not suspected, pre-alert secondary care about suspected sepsis and arrange emergency transfer to hospital (usually by 999 ambulance), depending on clinical judgement, if:<ul><li>There are any <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/assessment/\">high risk criteria</a> for severe illness or death from sepsis.</li><li>A child or young person is aged under 17 years, they are <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/background-information/risk-factors/\">immunocompromised or immunosuppressed</a>, and they have any <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/assessment/\">moderate-to-high risk criteria</a>.</li><li>There are any moderate-to-high risk criteria <em>and</em> the person does not have an identified underlying diagnosis or condition, <em>and/or</em> they cannot be safely treated in an out-of-hospital setting.</li><li>Note: consider managing the person in primary care if they are at high risk of severe illness or death from sepsis, but transfer of care to hospital would be unnecessarily burdensome or inappropriate, for example people who are very frail or approaching the end of life. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a> for more information.</li><li>Note: consider administering broad-spectrum antibiotics if there are any high-risk criteria in a pre-hospital setting, in locations where transfer time is more than one hour, depending on clinical judgement and local protocols.</li></ul></li><li>If there are any <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/diagnosis/assessment/\">moderate-to-high risk criteria</a> for severe illness or death from sepsis <em>and</em> a definitive diagnosis or condition has been identified <em>and</em> this can be treated in primary care:<ul><li>Manage any underlying condition and arrange further investigations and follow-up as appropriate, depending on clinical judgement.</li><li>Provide information on symptoms to monitor and clinical features of deterioration, and how to access emergency medical care if needed.</li></ul></li><li>If there are no high or moderate-to-high risk criteria:<ul><li>Manage the person according to clinical judgement.</li><li>Provide information on symptoms to monitor and clinical features of deterioration, and how to access emergency medical care if needed.</li></ul></li></ul><!-- end field bd0d3bff-fbbd-407b-b88e-aa0600a5693f --><!-- end item d5b074e3-9fc3-4255-a492-aa0600a5693f -->","subChapters":[{"id":"7f67ad9b-32ba-5b56-9279-72970c4f8667","slug":"specialist-assessment-management","fullItemName":"Specialist assessment and management","depth":4,"htmlHeader":"<!-- begin field 21bf0608-65f3-4676-9ad4-aa0600a5693f --><h4>Specialist assessment and management</h4><!-- end field 21bf0608-65f3-4676-9ad4-aa0600a5693f -->","summary":null,"htmlStringContent":"<!-- begin item 0e0964e2-461e-4f7b-b390-aa0600a5693f --><!-- begin field 4bbfb1f7-05f8-4826-bcf6-aa0600a5693f --><p><strong>Specialist assessment and management in an acute hospital setting involves implementation of the UK Sepsis Trust 'Sepsis Six' bundle within the first hour following recognition of sepsis:</strong></p><ol><li>Give oxygen therapy to people with reduced oxygen saturation or with an increase in oxygen requirement over baseline, to maintain oxygen saturation above 94% unless contraindicated.</li><li>Take blood tests and microbiology samples including:<ul><li>Blood gas including glucose and lactate measurement — hypoglycaemia may result from depleted glycogen stores; hyperglycaemia may result from the stress response to sepsis; hyperlactataemia is a non-specific indicator of cellular or metabolic stress and is a marker of illness severity, with a higher level predictive of higher mortality rates.</li><li>Blood culture — ideally done before antibiotic administration, to identify a primary bacteraemia.</li><li>Full blood count — white cell count may be high or low; thrombocytopenia may indicate disseminated intravascular coagulation (DIC).</li><li>C-reactive protein (CRP) — may indicate infection and/or inflammation.</li><li>Creatinine, urea and electrolytes — may indicate dehydration and/or acute kidney injury.</li><li>Liver function tests — increased bilirubin or alanine aminotransferase (ALT) levels may indicate cholestasis or other liver dysfunction.</li><li>Clotting screen — if abnormal may indicate coagulopathy/DIC.</li><li>Urine analysis and culture, chest X-ray, and additional investigations depending on the person's clinical presentation — this may allow identification of the source of infection, pathogen(s) and sensitivities, and subsequent tailoring and/or de-escalation of antibiotic therapy if appropriate. Source control to eliminate a focus of infection may be possible, such as abscess drainage, debridement of infected tissue, removal of infected devices or foreign bodies, or surgery.</li></ul></li><li>Give an intravenous broad-spectrum antibiotic at the maximum recommended dose. The choice of antibiotic will depend on the person's age, clinical presentation, most likely source of infection, recent antibiotic use, and local antibiotic prescribing guidelines.</li><li>Give an intravenous fluid bolus to restore tissue perfusion.</li><li>Check serial lactate measurement.</li><li>Check urine output, monitor fluid balance hourly and monitor the person's clinical condition. This may include using a track-and-trigger scoring system or early warning score to identify people at risk of deterioration.</li></ol><p><strong>Transfer to critical care may be needed to assess the need for central venous access and initiation of inotropes (increase cardiac output by increasing cardiac contractility) or vasopressors (increase blood pressure by increasing peripheral vascular resistance), to maintain perfusion pressure.</strong></p><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gauer, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Singer, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Keeley, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>]</p><!-- end field 4bbfb1f7-05f8-4826-bcf6-aa0600a5693f --><!-- end item 0e0964e2-461e-4f7b-b390-aa0600a5693f -->","subChapters":[]},{"id":"15d673bd-4984-5a2c-96f6-0d11192c6b01","slug":"basis-for-recommendation-c26","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 45f3edd7-a347-44f3-912a-aa0600a5693f --><h4>Basis for recommendation</h4><!-- end field 45f3edd7-a347-44f3-912a-aa0600a5693f -->","summary":null,"htmlStringContent":"<!-- begin item c26ee274-959f-4ab5-8546-aa0600a5693f --><!-- begin field 0310d63b-2f7f-4203-9ac9-aa0600a5693f --><p>The recommendations on how to manage a person with suspected infection and sepsis are largely based on the National Institute for Health and Care Excellence (NICE) clinical guidelines <em>Sepsis: recognition, assessment and early management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>] and <em>Neutropenic sepsis: prevention and management in people with cancer</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2012</a>], the international consensus report <em>Surviving Sepsis Campaign (SSC): International Guidelines for Management of Sepsis and Septic Shock: 2016</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>], a consensus document published by a Task Force of the Society of Critical Care Medicine and the European Society of Intensive Care Medicine <em>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Singer, 2016</a>], the UK Sepsis Trust <em>Sepsis Manual</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>], a Royal College of General Practitioners (RCGP) publication <em>Sepsis: guidance for GPs</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">RCGP, 2018</a>], a retrospective cohort study of the impact of delays in antibiotic therapy on mortality in septic shock [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Kumar, 2006</a>], a prospective cohort study of compliance with SSC performance criteria and mortality rates [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2014</a>], a retrospective analysis of SSC data [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Ferrer, 2014</a>], and expert opinion in review articles on sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gauer, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Keeley, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2018</a>].</p><h5>Managing suspected neutropenic sepsis</h5><ul><li>The recommendation on management of suspected neutropenic sepsis is based on the NICE clinical guideline on neutropenic sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2012</a>].</li></ul><h5>Arranging emergency hospital transfer</h5><ul><li>The NICE clinical guideline based its recommendations on the management of suspected sepsis in out-of-hospital settings on evidence reviews of physiological symptoms and signs, evidence reviews of interventions, and the experience and expertise of the guideline development group [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>].<ul><li>The NICE clinical guideline on sepsis notes that a delay in detecting and treating sepsis increases mortality rates. Prompt recognition and management of suspected sepsis can improve outcomes, as sepsis may progress rapidly to organ failure, septic shock, and death without appropriate management. Early management also reduces critical care admissions, inappropriate antimicrobial use, and length of hospital stay.</li><li>This is supported by expert opinion in an international SSC consensus report [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>], an international consensus document [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Singer, 2016</a>], the UK Sepsis Trust publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>], cohort studies of antibiotic administration and outcome [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Kumar, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Ferrer, 2014</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Gauer, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Keeley, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Cecconi, 2018</a>].<ul><li>The SSC consensus report best practice statement notes that sepsis and septic shock are medical emergencies, and treatment and resuscitation should begin immediately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>].</li><li>The UK Sepsis Trust publication notes the importance of pre-alerting hospital for all cases of suspected sepsis in the community [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>].</li><li>A retrospective observational cohort study of people with hypotension and septic shock (n = 2,154) found an association between delayed antibiotic initiation and death, with a 7.6% increase in risk of death for people in septic shock for every hour of delay in the first six hours since documented hypotension [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Kumar, 2006</a>].</li><li>A subsequent large international SSC retrospective database analysis of people in 165 intensive care units (n = 28,150) confirmed this association, and found that a delay in first antibiotic administration for people with sepsis and septic shock is associated with a statistically significant increase in hospital mortality. For each hour delay there is a linear increase in mortality risk [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Ferrer, 2014</a>].</li></ul></li></ul></li><li>The NICE clinical guideline recommends that people at high risk of sepsis (or moderate-to-high risk in certain clinical situations) should be given broad-spectrum antibiotics, intravenous fluid resuscitation, and other supportive measures as part of a bundle of care (set of protocols designed to standardize and streamline care) within one hour of identifying that the person meets any high risk criteria for severe illness or death from sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>]. The key immediate interventions that increase survival are described in a SSC-derived care bundle which has been developed by the UK Sepsis Trust ('Sepsis Six'), which has been shown to significantly reduce mortality when applied within the first hour of recognition of suspected sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>].<ul><li>An international prospective cohort study of the association between following SSC performance criteria and mortality rate (n = 29,470) found that compliance with SSC care bundles led to a 25% relative risk reduction in mortality [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2014</a>]. Similarly, a review article notes that compliance with bundled care for septic shock shows a consistent improvement in survival rates [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Keeley, 2017</a>].</li><li>The SSC guidelines strongly recommend administration of broad-spectrum intravenous antibiotics be initiated as soon as possible after recognition and within one hour for both sepsis and septic shock, based on moderate-quality evidence. Failure to initiate appropriate empirical drug therapy is associated with an increase in morbidity, including progression from Gram-negative bacteraemia to septic shock, and increased mortality. In addition, early effective fluid resuscitation is crucial for stabilization of sepsis-induced tissue hypoperfusion or septic shock [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2018</a>].</li><li>Overall, the Sepsis Six bundle aims to restore tissue hypoperfusion, treat underlying infection, identify the source of infection, assess for end-organ damage, and allow risk stratification [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Keeley, 2017</a>].</li></ul></li><li>The recommendation to consider managing the person in primary care if they are at high risk of severe illness or death from sepsis, but transfer of care to hospital would be unnecessarily burdensome or inappropriate is based on the expert opinion of an external reviewer of this CKS topic.</li><li>The recommendation to consider administering broad-spectrum antibiotics if there are any high risk criteria in a pre-hospital setting and transfer time to hospital is more than one hour is extrapolated from the NICE clinical guideline on sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>]. NICE recommends that ideally blood cultures should be taken before antibiotics are given, and this is supported by expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Levy, 2018</a>]. The recommendation on pre-hospital antibiotics is also pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Arranging follow-up in primary care if low risk of clinical deterioration</h5><ul><li>The recommendation to treat any underlying condition and arrange safety-netting and follow-up as appropriate for people not needing emergency transfer to hospital is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>], the UK Sepsis Trust publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>], the RCGP publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">RCGP, 2018</a>], and is also pragmatic based on what CKS considers to be good clinical practice.<ul><li>The UK Sepsis Trust publication notes that the absence of high- or moderate- risk criteria for deterioration suggest a low risk of adverse outcome from infection.</li><li>The RCGP publication stresses that safety-netting should be meaningful and include clinical features of deterioration of infection.</li></ul></li></ul><!-- end field 0310d63b-2f7f-4203-9ac9-aa0600a5693f --><!-- end item c26ee274-959f-4ab5-8546-aa0600a5693f -->","subChapters":[]}]},{"id":"aab50f34-1928-5a00-a3f3-f5dc283405fb","slug":"follow-up","fullItemName":"Follow-up","depth":3,"htmlHeader":"<!-- begin field 29f2d79f-ae8e-4fe2-9fc9-aa5400bf1fdb --><h3>How should I follow-up a person following confirmed sepsis?</h3><!-- end field 29f2d79f-ae8e-4fe2-9fc9-aa5400bf1fdb -->","summary":null,"htmlStringContent":"<!-- begin item b0f92a8b-c571-4930-b99a-aa5400bf1f9a --><!-- begin field 217f5686-1621-4319-bfbe-aa5400bf1fdb --><p><strong>If a person has had a confirmed diagnosis of sepsis following hospital discharge:</strong></p><ul><li>Provide the person and/or carers with advice on the nature of sepsis, what to expect during recovery after sepsis, and sources of information and support if this has not already been provided in hospital, such as:<ul><li>The UK Sepsis Trust is a national charity (website available at <a data-hyperlink-id=\"18d7172b-6572-45af-b026-aa6100c187d1\" href=\"https://sepsistrust.org/\" target=\"_blank\">sepsistrust.org</a>) for people or carers affected by sepsis, which has a telephone helpline (telephone 0808 8000029), runs local support groups for survivors of sepsis and their families/carers, and provides patient information booklets including <a data-hyperlink-id=\"c0acfcc5-9ec9-49e3-be8e-aa6100c187dd\" href=\"https://sepsistrust.org/wp-content/uploads/2018/06/updatedNew-Booklet-27-RD.pdf\" target=\"_blank\">Sepsis: a guide for patients and relatives</a>; <a data-hyperlink-id=\"bdbfbe0d-d35e-4f47-aa4b-aa6100c187ea\" href=\"https://sepsistrust.org/wp-content/uploads/2019/05/Recovery-After-Sepsis-Brochure-for-Web-Compressed-Final.pdf\" target=\"_blank\">Recovery after sepsis</a>; and <a data-hyperlink-id=\"a0a420c3-4dd7-4bbd-b9b8-aa6100c187f7\" href=\"https://sepsistrust.org/wp-content/uploads/2018/06/Legal-Brochure-update-2018-min-3.pdf\" target=\"_blank\">Practical and legal information</a>.</li><li>The NHS patient leaflet <a data-hyperlink-id=\"3fef9115-e57b-450e-b9a1-aa6100c18804\" href=\"https://www.nhs.uk/conditions/sepsis/\" target=\"_blank\">Sepsis</a>.</li></ul></li><li>Consider assessing for <a class=\"topic-reference internal-reference\" href=\"/topics/sepsis/background-information/complications/\">complications</a> following sepsis, if the person is not recovering as expected:<ul><li>If a person has symptoms of anxiety and/or post-traumatic stress disorder, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/post-traumatic-stress-disorder/\">Post-traumatic stress disorder</a> for more information on management.</li><li>If a person has persistent fatigue not attributable to other causes, consider referral to occupational therapy and/or physiotherapy for ongoing support. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/tiredness-fatigue-in-adults/\">Tiredness/fatigue in adults</a> for more information.</li><li>If a person has chronic pain not attributable to other causes, consider referral to a pain clinic for ongoing management.</li><li>If a person has recurrent episodes of confirmed sepsis and/or recurrent infections, consider referral to an Immunology specialist to assess for underlying causes of immunocompromise.</li><li>If a child has a family history compatible with primary immunodeficiency (such as complement disorders), ensure a referral to a paediatric immunologist has been arranged for further assessment, the urgency depending on clinical judgement.</li></ul></li></ul><!-- end field 217f5686-1621-4319-bfbe-aa5400bf1fdb --><!-- end item b0f92a8b-c571-4930-b99a-aa5400bf1f9a -->","subChapters":[{"id":"8c415b24-322b-52d4-94b3-c25ca6f9c374","slug":"basis-for-recommendation-222","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e447648c-6996-4af8-b8fe-aa5400bf1fe0 --><h4>Basis for recommendation</h4><!-- end field e447648c-6996-4af8-b8fe-aa5400bf1fe0 -->","summary":null,"htmlStringContent":"<!-- begin item 222b9806-daaa-4f84-ab0b-aa5400bf1fdf --><!-- begin field 72af0df8-43dd-4b97-a061-aa5400bf1fe0 --><p>The recommendations on follow-up are based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Sepsis: recognition, assessment and early management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>], the international consensus report <em>Surviving Sepsis Campaign (SSC): International Guidelines for Management of Sepsis and Septic Shock: 2016</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>], the UK Sepsis Trust <em>Sepsis Manual</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>], and expert opinion in a review article on sepsis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>].</p><ul><li>The recommendation on providing sources of information and support is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">NICE, 2019</a>], the UK Sepsis Trust publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>], and the SSC international consensus report which recommends that goals of care and prognosis are discussed with the person and families/carers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Rhodes, 2017</a>].<ul><li>The UK Sepsis Trust publication notes that literature on sepsis and its sequelae should be provided to the person and family to provide safety-netting advice, and information on possible adverse effects that may occur over the next few months following hospital discharge.</li></ul></li><li>The recommendations on identification and management of possible complications following sepsis are based on the UK Sepsis Trust publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Daniels, 2017</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>].<ul><li>The recommendations on the need for further assessment or referral to exclude immunocompromise or immunodeficiency if there are recurrent episodes of sepsis or a family history of immunodeficiency is based on expert opinion in a review article on sepsis in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sepsis/references/\">Plunkett, 2015</a>].</li></ul></li></ul><!-- end field 72af0df8-43dd-4b97-a061-aa5400bf1fe0 --><!-- end item 222b9806-daaa-4f84-ab0b-aa5400bf1fdf -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}